Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil for Glycemic Control in Cardiac Surgery
NCT02349152Phase 4Completed
- Start
- Jan 2016
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remifentanil in hyperglycemia. Primary endpoint: Percentage of patients with two or more intraoperative blood glucose levels > 180 mg/dL. Started Jan 2016; status: completed.
02
Drugs
remifentanil
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on NCT02349152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02349152.